Celsius Therapeutics joins other leading Biotech companies by choosing R&D Time for Project Time Collection and FTE reporting.
With offices in Cambridge, MA, Celsius' mission is to develop life-saving medicines and discover critical biomarkers for patient care by better understanding the cellular ecosystem of diseases through Single Cell Genomics and Machine Learning.
Located in Austin, TX, Molecular Templates is focused on the discovery, development and commercialization of next generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancer.
Headquartered in South San Francisco, CA, Atreca focuses on the immune response of patients in therapeutic areas where such responses are the key phenomenon driving clinical outcomes, enabling us to discover and develop novel immunotherapies, including those in our lead programs in Oncology.
With offices in Waltham, MA, Adagio's mission is to provide an effective long-term solution for the global Coronavirus challenge.
Beam Therapeutics is now a member of the R&D Logic Customer Community - welcome Beam!
With offices in Cambridge, MA, Beam Therapeutics is a biotechnology company committed to creating a new class of precision genetic medicines based on proprietary base editing technology, with a vision of providing life-long cures to patients suffering from serious diseases.
ShouTi Pharma, R&D Logic's newest customer, is using R&D Time for international project time collection.
Turnstone Biologics chooses R&D Time for Project Time Collection and FTE reporting.
With offices in Ottawa and New York City, Turnstone Biologics' mission is to deliver breakthrough viral immunotherapies to improve survival for patients with cancer.
Turning Point Therapeutics has selected R&D Logic as the corporate and portfolio FP&A solution.
Located in San Diego, CA, Turning Point Therapeutics has created a new generation of therapies that are different from the conventional kinase inhibitors. Their compact molecules are potentially more potent and selective medicines that also hold promise to prevent and overcome resistance.
Join us at the Westin Copley Place in Boston, MA, May 28-31, 2019
R&D Logic Panel: Thursday, May 30th, at 2:15. R&D Logic Panel Discussion Topic: "Financial and Resource Management - TARGETED Reporting and Dashboards – why it matters". Review the agenda and register here.
We appreciate Casebia Therapeutics for selecting R&D Logic's R&D Time for project time collection.
Located in Cambridge, MA, Casebia combines CRISPR/Cas9 expertise and technology from CRISPR Therapeutics with access to deep disease-state knowledge and protein engineering capabilities from Bayer.
RA Pharmaceuticals selects RDL5 with DIMENSIONS for portfolio planning, corporate planning, actuals tracking, reporting and graphical dashboards.
Located in Cambridge, MA, RA Pharma is a clinical-stage biopharmaceutical company using a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system.
Ondine Biomedical selects RDL5 with DIMENSIONS for portfolio planning, corporate planning, actuals tracking, reporting and graphical dashboards.
Located in Vancouver, BC, Ondine is focused on the development and commercialization of their patented light activated technology, photodisinfection. Photodisinfection provides rapid antimicrobial efficacy without encouraging the formation and spread of antibiotic resistance.
New customer alert! Sangamo Therapeutics, the latest life science company to select R&D Time for project time collection.
Located in Richmond, CA, Sangamo Therapeutics believes, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases.
R&D Logic is a proud sponsor of the 2018 ABFO National Conference
This years conference will be held in San Francisco, CA from May 29th to June 1st. Click here to see the agenda and register!
Flagship Pioneering recognized R&D Logic has best in class project time collection solution, R&D Time
Located in Cambridge, MA Flagship Pioneering fueled by curiosity and a quest for new sources of future value, conceives, creates, resources and grows first-in-category life sciences companies.
Armo Biosciences implements R&D Time for project time collection and FTE reporting
Located in Redwood City, CA ARMO BioSciences is a late-stage immuno-oncology company that is developing a pipeline of novel, proprietary products that activate the immune system of cancer patients to recognize and eradicate tumors.
R&D Logic releases RDL5 and Dimensions
Innovative Life Sciences Platform to Manage your R&D Portfolio. Click here for the press release.
Exelixis is now a member of the R&D Logic Customer Community - welcome Exelixis!
Founded in 1994, and located in South San Francisco, CA, Exelixis, Inc. is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers.
Welcome to the R&D Logic customer community Jaguar! We appreciate your selecting R&D Logic SaaS FP&A solution.
Located in San Francisco, CA Jaguar Animal Health is developing a pipeline of prescription drug product candidates and non-prescription products to address unmet needs in animal health.
Warp Drive Bio recognizes R&D Logic's life sciences expertise and selects R&D Time for project time collection!
Located in Cambridge, MA, Warp Drive Bio operates on the core principle that nature is the most powerful inventor of new drugs, unconstrained by the boundaries of modern science.
R&D Logic is a proud sponsor of the 2017 ABFO National Conference.
This years conference will be held in Philadelphia from May 30th - June 2nd. Click here to see the agenda and register!
IGM Biosciences goes with the industry leader and selects R&D Logic's R&D Time for project time collection!
Located in Mountain View, CA, IGM Biosciences is dedicated to helping patients world-wide by creating and developing novel IgM and IgA antibodies which improve the treatment of cancer and infectious diseases.
Cerecor joins the R&D Logic customer community.
Located in Baltimore, MD, Cerecor Inc. joins the growing list of Biotech and Pharmaceutical companies convinced that doing business with a software company dedicated to life sciences is the right choice. Cerecor Inc. is a clinical-stage biopharmaceutical company with the goal of becoming a leader in the development of innovative drugs that make a difference in the lives of patients with neurological and psychiatric disorders.
Biospace features R&D Logic in spotlight article.
Click here to read more.
R&D Logic's R&D Time is the software of choice for Intellia Therapeutics for project time collection and FTE reporting.
Located in Cambridge, MA, Intellia Therapeutics is the most recent Biotech company to recognize R&D Logic's unique life sciences specialization. Intellia's combination of deep scientific expertise and clinical development experience, along with their leading intellectual property portfolio, puts them in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create a new class of therapeutic products.
R&D Logic's life science focused software suite has been selected by Karyopharm Therapeutics, Inc. for planning, project costing, time collection and reporting.
Located in Newton, MA, Karyopharm Therapeutics is the latest life science company in this explosive Biotech hub to select the R&D Logic solution to manage their R&D intensive company. Karyopharm's mission is to discover and develop first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases.
Spero Therapeutics, Inc. has chosen the R&D Logic platform for project time collection, project costing and FTE reporting.
Located in Cambridge, MA, Spero Therapeutics is the latest life science company to select R&D Logic's Life Sciences specialty solution to manage their R&D intensive company. Spero's mission is to develop, and advance groundbreaking therapeutics to meet critical patient needs in infectious disease.
R&D Logic is a proud sponsor of the 2016 ABFO National Conference.
This years conference will be held in San Diego from May 24th - 27th. Click here to see the agenda and register!
Balance Therapeutics, Inc. selects the R&D Logic platform for project time collection and FTE reporting.
Located in San Bruno, CA, Balance Therapeutics has selected R&D Logic's Life Sciences specialty solution to manage their R&D intensive company. Balance is focused on developing therapeutics to address neurological disabilities resulting from excess inhibition of the brain.
Nurix, Inc. selects the R&D Logic platform for project time collection, FTE reporting and project costing.
Located in San Francisco, CA, Nurix has selected R&D Logic's Life Sciences specialty solution to manage their R&D intensive company. Nurix is passionate in its mission of pioneering the development of small molecules that modulate the ubiquitin proteasome system (UPS) for improvement of human health.
Forma Therapeutics selects the R&D Logic platform for corporate planning, portfolio planning, tracking, time collection and reporting.
Located in Watertown, MA, Forma Therapeutics has selected the R&D Logic FP&A solution to manage their R&D intensive company. Forma is passionate about discovering and developing medicines that will make a difference in cancer and other genetically-driven diseases.
R&D Logic To Present At CBI Conference, The Life Sciences R&D Financial Tracking & Analysis Summit - November 16-17, Philadelphia
Please click here for the press release.
Viking Therapeutics selects the R&D Logic platform for corporate planning, portfolio planning, tracking, time collection and reporting.
Viking, located in San Diego, California has selected R&D Logic's software for planning, tracking, analysis and reporting. Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders.
R&D Logic To Present At CBI's Life Sciences R&D Financial Tracking & Analysis Summit, November 16-17, in Philadelphia.
Watch for more information to follow.
R&D Logic to Present at ABFO's Southern California Chapter Meeting, September 23, 2015.
Just Biotherapeutics selects the R&D Logic solution for corporate planning and reporting
Just, located in Seattle, Washington has selected R&D Logic's software for planning, tracking, analysis and reporting. Just is an integrated design company focused on the technology of biotherapeutics, from molecule to manufacturing plant. Just believes that technological innovation will accelerate biotherapeutic development and dramatically reduce the cost of these vital medicines.
R&D Logic To Present At CBI Conference, 11th Life Sciences Accounting & Reporting Congress, March 16-18 In Philadelphia
Please click here for the press release.
Retrophin selects the R&D Logic time collection solution
Retrophin, located in New York, Cambridge and San Diego has selected R&D Logic's software for collecting and reporting R&D project effort and FTEs. Retrophin is a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of drugs for the treatment of debilitating and often life-threatening diseases for which there are currently limited patient options.
Juno Therapeutics selects the R&D Logic solution for corporate planning and reporting
Juno, located in Seattle, Washington has selected R&D Logic's software for planning, tracking, anlysis and reporting. Juno is a clinical-stage company that brings together three of the world's leading cancer centers - Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children's Research Institute - in unique partnership to advance a broad pipeline of breakthrough immunotherapies.
Accelleron Pharma selects the R&D Logic solution for R&D project effort
Acceleron, located in Cambridge, Massachusetts has selected R&D Logic's software for collecting and reporting project effort and FTEs. Acceleron aims to transform the lives of people suffering from cancer and orphan diseases by discovering and developing innovative therapies.
Mersana Therapeutics selects the R&D Logic time collection solution
Mersana, located in Cambridge, Massachusetts has selected R&D Logic's software for collecting and reporting project effort and time off. Mersana engineers novel drug conjugates that maximize the potential of new and established therapeutic classes. Mersana technology harnesses the power and synergy of nanotechnology, biologics and small molecules has built a portfolio of innovative therapeutic antibodies, both in late-stage clinical development and in preclinical research.
XOMA Corporation selects the R&D Logic platform
XOMA Corporation, located in Berkeley, California has selected R&D Logic platform to support global planning, tracking and reporting of the R&D porfolio and the overall corporation. XOMA has built a portfolio of innovative therapeutic antibodies, both in late-stage clinical development and in preclinical research.
Archives
Customer News
Ipsen Biomeasure, a subsidiary of Ipsen, located in Milford, Massachusetts has selected R&D Logic software and services to manage their planning, tracking and reporting processes. Biomeasure is one of the research centers of the Ipsen Group and is focused on discovering drugs in neuro-endocrinology.
Sutro Biopharma signs up to R&D Logic software and services
Sutro Biopharma, located in South San Francisco, California has selected R&D Logic software and services to develop long term, mid-term and operational budgetes and to track, analyze and manage variances to actual results. In addition, Sutro employees and contractors will track their time effort to project using the RDLogic platform. Sutro Biopharma is developing a new generation of multi-functional antibody drug conjugate combination therapeutics and bifunctional antibody-based therapeutics for targeted cancer therapies.
Sarepta Therapeutics selects R&D Logic software
Sarepta Therapeutics, located in Cambridge, Massachusetts has selected R&D Logic software and services to manage corporate planning, tracking, analysis and reporting. Sarepta Therapeutics is focused on developing first-in-class RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases.
Tetraphase Pharmaceuticals selects R&D Logic software
Tetraphase Pharmaceuticals, located in Watertown, Massachusetts has selected R&D Logic software and services to automate FP&A processes: planning, tracking, analysis and reporting. Tetraphase is a clinical-stage biopharmaceutical company using its proprietary chemistry technology to create novel antibiotics for serious and life-threatening multi-drug resistant (MDR) infections.
Enanta Pharmaceuticals selects R&D Logic platform software
Enanta Pharmaceuticals, located in Watertown, Massachusetts has subscribed to R&D Logic software and services to manage corporate planning, tracking, reporting as well as time collection processes. Enanta is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field.
BIND Biosciences selects R&D Logic's Time Collection software
BIND Biosciences, located in Cambridge, Massachusetts has subscribed to R&D Logic software and services for collecting, managing and reporting collaborator project time, project FTEs as well as time off. BIND is a clinical-stage biopharmaceutical company developing a new class of highly selective targeted therapeutics called Accurins.
Solazyme selects R&D Time software and services
Solazyme, located in South San Francisco, California has subscribed to R&D Logic software and services as the corporate-wide solution for collecting, managing and reporting project effort, FTEs as well as time off. Solazyme has pioneered an industrial biotechnology platform that harnesses the prolific oil-producing ability of microalgae.
PNI Digital Media Inc. selects R&D Logic software and services
PNIDigitalMedia, located in Vancouver, Canada has subscribed to R&D Logic software and services for managing planning, tracking, consolidation reporting as well as time collection. At its core, PNI Digital Media provides a proprietary transactional software platform that is used by leading retailers such as Costco, Walmart Canada, and CVS/pharmacy to sell millions of personalized products every year.
Pfenex, Inc. selects R&D Logic software platform and services
Pfenex, located in San Diego, California, has subscribed to R&D Logic software and services for managing planning, tracking, analysis and consolidation reporting. Pfenex is a leading biotechnology company focused on recombinant protein expression for a broad range of applications including therapeutic proteins, vaccines, research, reagents and biosimilars.
EnVivo Pharmaceuticals, Inc. subscribes to R&D Logic software and services
EnVivo, located in Watertown, Massachusetts, has subscribed to R&D Logic software and services for managing FP&A corporate processes. EnVivo is developing its broad pipeline of diverse programs with a focus on leveraging novel mechanisms of action to treat CNS diseases like schizophrenia and Alzheimer’s disease in new ways and from multiple angles.
Aveo Pharmaceuticals, Inc. subscribes to R&D Logic Time Collection & Reporting software and services
AVEO, located in Cambridge, Massachusetts, has subscribed to R&D Time software services to manage time collection, FTE and collaborations reporting. AVEO Oncology is a cancer therapeutics company committed to discovering, developing and commercializing targeted therapies to impact patients’ lives.
Epizyme, Inc. selects R&D Logic Plaform for the Business of Science
Epizyme, located in Cambridge, Massachusetts, has subscribed to R&D Logic software and services for planning, tracking, time collection and consolidated reporting of the R&D Portfolio and of Corporate Financials. Epizyme is leading the discovery and development of small molecule histone methyltransferase(HMT)inhibitors, a new class of personalized therapeutics for the treatment of patients with genetically-defined cancers, based on breakthroughs in the field of epigenetics.
OncoGenex Pharmaceuticals, Inc. selects R&D Logic Planning and Tracking Software
OncoGenex, located in Vancouver, Canada and Seattle, Washington, has subscribed to R&D Logic software and services for planning and tracking, and financial reporting. OncoGenex Pharmaceuticals is a drug discovery and development company uniquely focused on the challenge of cancer treatment resistance.
RealD Inc. selects R&D Logic enterprise platform for the R&D Division
RealD, located in Beverly Hills, California, has subscribed to R&D Logic software services to manage planning, tracking and time collection for their Colorado based Research & Development division. RealD is a leading global licensor of stereoscopic (three-dimensional), or 3D, technologies. Its extensive intellectual property portfolio enables a premium 3D viewing experience in the theater, the home and elsewhere.
Vitapath Genetics, Inc. subscribes to R&D Logic CPM software and services
<pVitapath Genetics, Inc., located in Foster City, California, has subscribed to R&D Logic software services to manage planning, tracking, time collection and corporate reporting. VitaPath Genetics is developing a family of DNA tests to help individuals reduce the risk of serious and life-threatening disease.Affymax, Inc. subscribes to R&D Logic Time Collection & Reporting software and services
Affymax, located in Palo Alto, California, has subscribed to R&D Time software services to manage time collection, FTE and collaborations reporting. Affymax is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions.The company’s product candidate, peginesatide (formerly known as HematideTM), has been investigated in Phase 3 trials for the potential treatment of anemia associated with chronic renal failure.
NovaBay Pharmaceuticals, Inc. selects R&D Time software and services
NovaBay, located in Emeryville, California, has subscribed to R&D Time software services to manage time collection and collaborations' reporting. NovaBay is a clinical stage biotechnology company focused on developing its proprietary and patented topical Aganocide compounds.
Anthera Pharmaceuticals, Inc. selects R&D Logic Planning and Tracking Software
Anthera, located in Hayward, California, has subscribed to R&D Logic software and services for planning and tracking, and financial reporting. Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious illnesses, including cardiovascular and autoimmune diseases.
Adamas Pharmaceuticals, Inc. upgrades R&D Logic services with R&D Time
Adamas, a long term customer of R&D Logic, has added R&D Time to their suite of services. R&D Time is being utilized to collecting and tracking time effort, with an emphasys on NIH grants. Adamas Pharmaceuticals is an emerging pharmaceutical company focused on developing small molecule Advantaged Therapeutics. Adamas Pharmaceuticals is headquartered in Emeryville, California, with operations in Bangalore, India.
Athersys, Inc. selects R&D Logic Planning and Tracking Software
Athersys, located in Cleveland, Ohio, has subscribed to R&D Logic software and services for corporate planning and tracking, and financial reporting. Athersys is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. Through the application of our proprietary technologies, we have established a pipeline of therapeutic product development programs in multiple disease areas.
Trius Therapeutics, Inc. selects R&D Logic Planning and Tracking Software
Trius Therapeutics, located in San Diego, California, has chosen R&D Logic software for corporate and research contracts planning and tracking, budgeting and forecasting. Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections.
Prognosys Biosciences selects R&D Logic Software
Prognosys Biosciences, located in La Jolla, California, has chosen R&D Logic software for corporate planning and tracking, financial reporting, and time collection. Prognosys is an early-stage biotechnology company focusing on the promising and rapidly developing field of personalized medicine. Prognosys carries out R&D in the area of novel assays and biomarker discovery, and uses next-generation sequencing technologies for the analysis of complex systems.
Hyperion Therapeutics, Inc. selects R&D Manage software for planning and tracking
Hyperion Therapeutics, Inc., located in South San Francisco, California, has subscribed to R&D Logic software services to manage planning and tracking of corporate revenues, expenses and resources. Hyperion Therapeutics is a privately held pharmaceutical company focused on the development of treatments that address critical unmet needs in the areas of gastroenterology and hepatology.
MacroGenics, Inc. selects R&D Manage software for planning and tracking
MacroGenics, Inc., located in Rockville, Maryland, has subscribed to R&D Logic software services to manage world-wide corporate planning and tracking,budgeting and forecasting, and financial reporting. MacroGenics'mission is to discover, develop and deliver to patients novel biologics for the treatment of autoimmune disorders, cancer and infectious diseases.
Facet Biotech Corporation selects R&D Time software and services
Facet Biotech, located in Redwood City, California, has subscribed to R&D Time software services to manage corporate budgeting and forecasting, time collection, and project FTE reporting. Facet Biotech Corporation launched in December 2008 as a spin-off from PDL BioPharma, Inc. Combining expertise in antibody engineering with a disciplined, biology-driven research approach, Facet Biotech is dedicated to advancing our current pipeline of four clinical-stage products and leveraging our research and development capabilities to identify and develop new drugs.
Inviragen, Inc. subscribes to R&D Time software and services
Inviragen, Inc.located in Fort Collins, Colorado, has subscribed to R&D Time software services to manage world-wide time collection and grant reporting. Inviragen is focused on developing life-saving vaccines to protect against emerging infectious diseases worldwide.
KaloBios Pharmaceuticals, Inc. subscribes to R&D Time software and services
KaloBios Pharmaceuticals, located in South San Francisco, California, has subscribed to R&D Time software services to manage corporate time collection and project FTE reporting.KaloBios uses its biologic capabilities and its proprietary platform technology to develop first-in-class human antibody therapeutics.
Medivation, Inc. selects R&D Logic complete software solution and services
Medivation, Inc., located in San Francisco, California, has subscribed to R&D Logic software services for planning and tracking expenses and resources at the corporate and project portfolio levels as well as for collecting and tracking R&D project time to collaborators and to internal management. Medivation is is a biopharmaceutical company with small molecule drugs in clinical development to treat three large, unmet medical needs.
Nevro Corporation subscribes to R&D Manage software services
Nevro Corporation, located in Palo Alto, California, has subscribed to R&D Manage software service for planning and tracking expenses and resources at the corporate and project portfolio levels. Nevro is a medical device company developing novel neuromodulation therapies for multiple indications.
Portola Pharmaceuticals, Inc. subscribes to Time Collection and Financial Reporting software service
Portola Pharmaceuticals located in South San Francisco, California, has subscribed to R&D Time software service to manage all corporate time collection, financial reporting, and project FTE reporting. Portola is discovering and developing novel therapeutics to meet patient needs in cardiovascular, inflammation, and oncology indications.
Ambrx, Inc. chooses R&D Time software service
Ambrx, located in La Jolla, California, has subscribed to R&D Time software service to collect, track and report project effort. Special emphasys will be put on tracking effort by collaborator. Ambrx, Inc. is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics.
Neurobiological Technologies, Inc. fast tracks the use of R&D Logic Budgeting Software
NTI, located in Emeryville, California, has chosen R&D Logic budgeting software to create the next corporate plan. Neurobiological Technologies, Inc. is a biotechnology company engaged in the business of acquiring and developing central nervous system (CNS) related drug candidates.
Tercica, Inc. selects R&D Logic Software
Tercica, Inc., located in Brisbane, California, has chosen R&D Logic software for corporate planning, collecting and tracking, and financial reporting. Tercica is a biopharmaceutical company working to develop and commercialize therapeutics for growth and other endocrine disorders.
Savient Pharmaceuticals selects R&D Logic Software
Savient Pharmaceuticals, located in East Brunswick, New Jersey, has selected R&D Logic software for corporate planning, collecting and tracking, and financial reporting. Savient Pharmaceuticals is a specialty biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.
Catalyst Biosciences selects R&D Logic Software
Catalyst Biosciences, located in South San Francisco, California, has opted to use R&D Logic software for time collection efforts, while planning and tracking project resources. Catalyst Biosciences is a leading biotechnology company focused on developing proteases as a therapeutic platform for inflammation, cardiovascular, and angiogenesis-based disorders.
Via Pharmaceuticals, Inc. selects R&D Logic Software
Via Pharmaceuticals, Inc., located in San Francisco, California, has selected R&D Logic enterprise software for financial planning and analysis, consolidated reporting as well as for project time collection and project portfolio specific planning and tracking. VIA is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease.
Kalypsys, Inc. selects R&D Logic Software
Kalypsys, Inc., located in San Diego, California, has chosen R&D Logic software for tracking and planning project resources and time effort. Kalypsys is a clinical stage pharmaceutical company that is advancing the way drugs are discovered and developing breakthrough therapies for some of the world's most widespread diseases including cardiovascular/metabolic diseases, pain/inflammation and oncology.
FivePríme Therapeutics, Inc. selects R&D Logic Software
Five Príme Therapeutics, Inc., located in San Francisco, California, has selected R&D Logic software for planning and tracking, and time collection. FivePríme Therapeutics, Inc. is a pre-clinical stage biotech company discovering and developing innovative protein and antibody therapeutics. FivePríme is developing treatments for cancer and diabetes and multiple leads in metabolic and immunologic diseases, oncology and regenerative medicine.
Macroflux Corporation selects R&D Logic Software
Macroflux Corporation, located in Mountain View, California, has opted to use the R&D Logic complete enterprise solution for planning and tracking, and time collection. Macroflux is a spin-out of ALZA Corporation (a subsidiary of Johnson & Johnson). The Macroflux system is based on a small patch and applicator that is intended to provide a needle-free solution for transdermal delivery of therapeutic proteins, peptides and vaccines. It is designed to combine painless and convenient drug administration with rapid delivery and high bioavailability.
SGX Pharmaceuticals selects R&D Logic Software for Planning and Tracking
SGX Pharmaceuticals Inc., located in San Diego, California, has decided to use R&D Logic enterprise solution to support FP&A company-wide processes. SGX Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics.
Alnylam Pharmaceuticals selects R&D Logic Software
Alnylam Pharmaceuticals Inc., located in Cambridge, Massachusetts, has selected R&D Manage, R&D Time and R&D P&L to support corporate strategic and financial planning as well as monthly tracking and analysis. Alnylam Pharmaceuticals, a leader in RNAi therapeutics, is a biopharmaceutical company developing novel therapeutics based on a breakthrough in biology known as RNA interference, or RNAi.
Momenta Pharmaceuticals selects R&D Logic Enterprise Solution
Momenta Pharmaceuticals Inc., located in Cambridge, Massachusetts, has selected R&D Logic suite of software to support planning and tracking, time collection and corporate analysis and financial reporting. Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the detailed structural analysis and design of complex sugars (polysaccharides) for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes.
InterMune chooses R&D Resource software
InterMune Inc., located in Brisbane, California, has opted to use R&D Logic software to support Project Time collection as well Time off collecting and tracking, our latest addition to the enterprise solution. In addition, InterMune will be using software capabilities to track and analyze resource utilization by project and program. InterMune is a publicly traded biotech company focused on developing and commercializing innovative therapies in hepatology and pulmonology.
Titan Pharmaceuticals chooses R&D Logic suite for Planning and Tracking
Titan Pharmaceuticals Inc., located in South San Francisco, California, has selected the full R&D Logic suite of software to support corporate planning and tracking, time collection, and financial reporting. Titan is a biopharmaceutical company focused on the development and commercialization of novel treatments for central nervous system disorders, cardiovascular disease, bone disease and other disorders.
Valentis selects R&D Time solution for tracking actual project effort
Valentis, Inc., located in Burlingame, California, has selected R&D Time to replace in-house time and attendance system and complete the R&D Logic enterprise suite that has been in used for the past four years. Valentis is a biotechnology company engaged in the development of innovative products for peripheral arterial disease (PAD), a large and unsatisfied market.
Avidia selects R&D Logic enterprise solution for planning and tracking
Avidia, Inc. located in Mountain View, California, has selected R&D Manage, R&D Time and R&D P&L to support corporate strategic and operational planning as well as monthly collecting and tracking. Avidia is focused on developing a new class of therapeutic proteins for treatments in areas including autoimmunity, inflammation and oncology.
NeuroMolecular selects R&D Logic solution for corporate planning and tracking
NeuroMolecular Pharmaceuticals, Inc., located in Emeryville, California has selected R&D Manage™ and P&L platform to support project portfolio and corporate planning and tracking business processes. NeuroMolecular Pharmaceuticals is developing and commercializing superior neuroprotective medicines for the treatment of central nervous system (CNS) disorders.
EPIX Pharmaceuticals selects R&D Time™ as the new company time & attendance solution
Epix, who currently uses R&D Manage for their corporate budgeting and tracking, has decided to expand their usage of R&D Logic products and include R&D Time, a software tool specifically developed to collect project efforts by employee. R&D Time will replace the current time collection system.
Avigen selects R&D Logic solution for planning and tracking corporate financials
Avigen, Inc. located in Alameda, California has selected R&D Manage and R&D Time software to support corporate and project planning and tracking activities. Avigen (NASDAQ: AVGN) is a leader in the development of gene therapy products to treat serious, chronic diseases.
EPIX Medical selects R&D Manage™ solution for planning and tracking resources by project
EPIX Medical, Inc. located in Cambridge, Massachusetts has selected R&D Logic software solution and services for managing their corporate and project financials. EPIX Medical (NASDAQ: EPIX)is a specialty pharmaceutical company and a worldwide leader in the discovery and development of targeted MRI contrast agents for the diagnosis and clinical management of disease.
R&D Logic's Customers Meet Over the Web
In an effort to better serve our customers, R&D Logic organizes quarterly webinars to discuss topics of common interest. The first such webinars are beeing held this month to present new features of the latest product release. Watch for anouncements of future topics!
BioMedicines selects R&D Manage™ solution to budget, forecast and track their financials and project resources
BioMedicines, Inc. located in Emeryville, California has selected R&D Logic software solution and services for managing their corporate and project financials. BioMedicines specializes in developing and systematically generating new uses for clinical-stag drugs purchased or licensed from major pharmaceutical companies.
NPS Pharmaceuticals has selected the R&D Manage™ solution to support budgeting and forecasting of their world wide expenses
NPS Pharmaceuticals, Inc. located in Salt Lake City, Utah has subscribed to R&D Logic software solution and services. NPS Pharmaceuticals was founded in 1986 and is engaged in the discovery and development of novel, small molecule drugs and recombinant peptides that address a variety of important diseases. With operations in both US and Canada, NPSP will start using the R&D Manage software by developing a detailed global budget across the various organizations.
Discovery Partners International has selected the R&D Manage™ solution to plan and track their consolidated financials
Discovery Partners International, Inc. located in San Diego, California has subscribed to R&D Logic software solution and services. Discovery Partners has become a leader in drug discovery collaborations by offering integrated services and products that span the drug discovery continuum including target characterization, high throughput screening, lead generation, lead optimization, high throughput synthesis automation, and gene expression analysis. With operations in both US and Europe, DPI will start using the R&D Manage software by developing a detailed global budget for the entire corporation.
Novacea has opted for the R&D Manage™ solution to plan and track their financials
Novacea, Inc. located in South San Francisco, California has subscribed to R&D Logic software solution and services. Novacea is a rapidly growing drug development company that has the exclusive worldwide rights to the Oregon Health & Science University (OHSU) technology for dose and a method of use of calcitriol and its analogs, potentially providing a major breakthrough in the treatment of cancer. R&D Manage will be first used to create a long range plan of the Company financials, with an emphasis on clinical trial costs.
Guilford Pharamceuticals has selected R&D Manage™ solution to support their objective driven financial planning and tracking process
Guilford Pharmaceuticals, Inc. located in Baltimore, Maryland has subscribed to R&D Logic software solution and services. With implementation efforts already under way, we are looking forward to integrating the R&D Manage software within a unified platform for budgeting and forecasting of the Guilford financials.
CellGate has selected R&D Manage™ to support budgeting and forecasting monthly reporting activities for their rapidly expanding operations.
CellGate, Inc. located in Sunnyvale, California has subscribed to R&D Logic software solution and services. CellGate is a pioneer in the application and development of transporter molecules to deliver novel medicines into cells and through tissues.
Neurogen (Connecticut) and Pharmos (New Jersey) have selected R&D Manage to support their budgeting and forecasting monthly reporting activities.
NEUROGEN Corporation has acquired a global license for using R&D Manage software and services. Neurogen is a leader in both the discovery and development of new drug candidates and in the development and integration of new drug discovery technologies, most notably its AIDD (Accelerated Intelligent Drug Discovery) system.
PHARMOS Corporation has subscribed to R&D Manage software and services. Additionally, R&D Manage will support consolidation between the Israel and US divisions. Pharmos Corporation is a bio-pharmaceutical company focused on the discovery, development and commercialization of therapeutics for the central and peripheral nervous systems, and ophthalmologic, cardiovascular and inflammation-related indications.
Neurogenetics acquires global license for using R&D Manage.
NEUROGENETICS, Inc. has subscribed to R&D Manage software and services. Neurogenetics is a San Diego-based emerging biopharmaceutical company focused on the development of therapeutics for Alzheimer's disease (AD) and related neurodegenerative disorders, including Parkinson's disease (PD), Huntington’s disease (HD), stroke, amyotrophic lateral sclerosis (ALS), epilepsy and chronic pain.
HYSEQ and ZYOMYX have selected R&D Manage™ to plan and track their operating expenses.
Hyseq, Inc. and Zyomyx have recently subscribed to R&D Manage software and services. Hyseq, located in Sunnyvale, California, applies its genomics platform to find and develop biopharmaceuticals products. Zyomyx, located in Hayward, California, is developing a new generation of biochips which will enable miniaturized, ultrahigh-throughput protein analyses to bridge the technology gap in the discovery process for the biological and life sciences industry.
10 biotech and pharmaceutical companies are now using our solution for budgeting and forecasting, planning and tracking.
NeoTherapeutics, Inc. and Metabolex, Inc. have recently joined our user community. NeoTherapeutics, located in Irvine, California, is a development-stage biopharmaceutical company engaged in the discovery and advancement of novel therapeutic agents intended to treat neurological and psychiatric diseases and conditions. Metabolex discovers and develops new drugs for type 2 diabetes and brings to market novel drugs with distinct and complementary modes of action, to address the full range of defects underlying diabetes. Both companies will be using R&D Manage on a subscription mode and will first use the system to create their 2002 budgets.
Valentis, Inc. has subscribed to R&D Manage.
Valentis, Inc, is taking the discoveries of genomics research and applying proprietary delivery systems to create therapeutics with improved safety, efficacy or dosing convenience. Valentis has what is believed to be the broadest array of technologies and intellectual property for the delivery of biopharmaceuticals in the industry. R&D Manage will be integrated with Platinum and the local time reporting system. The company has centers in three locations: The Woodlands, Texas, which houses the team focused on preclinical Research & Development; London, England, where PolyMASC operates as a wholly-owned subsidiary and focuses on polymer-based delivery; and Burlingame, California, which is the company headquarters as well as the center for manufacturing and clinical development. R&D Manage will be rolled out to the US locations in April 2001.
Intrabiotics has subscribed to R&D Manage.
Intrabiotics Pharmaceuticals Inc, is a biopharmaceutical company developing novel antibacterial and antifungal drugs for the prevention or treatment of serious infectious diseases, including those related to the phenomenon of multi-drug resistant microbes and the infectious complications of neutropenia. R&D Manage™ will be integrated with MAS90 and local time reporting system.
Sunesis and Cytokinetics Inc. have also joined our R&D Manage subscription community.
Sunesis Pharmaceuticals is applying a revolutionary new approach to drug discovery that is based on a novel chemical methodology combined with critical insights into the nature of molecular recognition between natural macromolecules and their substrates or ligands. Sunesis will be using R&D Manage™ and the electronic integration with Quick Books. Cytokinetics Inc. is focused on the complementary missions of drug discovery and the commercialization of novel cellular bioinformatics technologies. We are excited to integrate R&D Manage™ with the General Ledger of Microsoft Dynamics accounting system.
BioSpace.com has subscribed to R&D Manage
BioSpace.com, Inc. is the most heavily trafficked business-to-business life sciences site on the Internet today. The company has selected R&D Manage as the tool to budget and forecast their P&L by project and by organization.
GeneSoft chooses R&D Manage over Hyperion
GeneSoft, Inc. a South San Francisco company focused on pharmaceuticals that modulate gene expression, has subscribed to R&D Manage with Quick Books to budget and forecast R&D expenses.
Collabra Pharma leases R&D Manage
Collabra Pharma, Inc., a drug development company based in South San Francisco, has chosen R&D Manage™ with Quick Books to manage their budgeting and tracking of R&D expenses.
Product News
R&D Logic introduces R&D GRANT to support planning and tracking grants from NIH, DARPA, SBIR, other government agencies or private foundations
With R&D GRANT, customers can ensure that funds are fully drawn and that indirect costs are recovered. click here to learn more about this new offerring.
R&D Logic releases R&D MANAGE 4.0
This major release features a brand new interface, along with many new user friendly features:
- New looks, colors, fewer clicks and streamlined navigation
- New mechanism to submit and browse reports
- New mechanism to list, search and update information
R&D Logic introduces R&D SELECT to support dynamic selection from a robust menu of software and services
With R&D SELECT, customers can choose from pre-configured scenarios or, build their own! click here to learn more about this new offerring.
R&D Time 3.1.1 Release Launch
R&D Logic announces new product features for its R&D Time Module setting a new standard in integrating planning and resource time tracking software offerings. (press release) To learn more about this product's functionality, click here.
R&D P&L 2.0 Release Launch
R&D P&L has been enhanced with additional flexibility for defining financial reporting criteria as well as new publishing features for easy distribution. There are currently seven different companies that have purchased this application and are successfully using it for producing and distributing monthly and pro-forma financials. To learn more about this product's functionality, click here.
R&D Manage™ 3.1 Release Launch
R&D Manage 3.1 release has been rolled out to all customer. This new release incorporates functions in project resources and financials tracking, as well as new reporting tools.
R&D P&L Commercial Launch
R&D P&L complements R&D Manage and supports the calculation, formatting, viewing (including drill-down) and direct download to Excel of a Company's Profit & Loss Statement. The module also automates allocations (Facility, G&A, &D, Cost of Goods Sold, etc.) required to produce a complete P&L statement. To learn more about this product's functionality, click here.
R&D Time 1.0
R&D Time 1.0 release has been commercially launched to two sites. The response from customers has been overwhelmingly positive and enthusiastic. To learn more about this product's functionality, click here.
R&D Manage 3.0
The R&D Manage 3.0 release has been rolled out to all customers. This major release introduces an enhanced reporting mechanism, a complete rewrite of most standard reports along with a new technology to seamlessly download reports to Excel. Customer response has been extremely enthusiastic. To learn more about this product's functionality, click here.
R&D Time Beta Customers
Cytokinetics and Novacea have signed up as beta customers of our latest product under development, R&D Time. This new product facilitates capturing the employees' monthly effort by project along with providing electronic approvals, alerts and graphical analysis of project resources utilization across the corporation.
J2EE Platform
R&D Logic has adopted J2EE as its new strategic technical platform. New products under development are switched to the new technology. R&D Logic is also pleased to announce the hiring of Mr. Wayne Kidd to spearhead the implementation of the J2EE architecture and platform. Mr. Kidd, well known by the Java community, brings a wealth of technical expertise and product development experience to our efforts.
R&D Manage Release 2.2.1
The newest release of R&D Manage product has been rolled out to all current customers. The software functionality has been expanded with additional direct and indirect project costing capabilities. To learn more about this product's functionality, click here.
R&D Manage Release 2.2
The newest release of R&D Manage product has been rolled out to all customers. The software functionality has been expanded with additional currency exchange, planning and reporting capabilities. To learn more about this product's functionality, click here.
R&D Manage Release 2.1.7
The newest release of R&D Manage product has been rolled out to all customers. The software functionality has been expanded with additional reporting capabilities. To learn more about this product's functionality, click here
R&D Manage Release 2.1
The newest release of R&D Manage product has been rolled out to all customers. The software functionality has been expanded to include budgeting based on standard rates; existing functions have been improved and enhanced as well.
Company News
R&D Logic Appoints John Whiting and Scott Clarke to its Board Of Directors
"Our new Board members bring more than 50 years of combined experience in the Life Sciences and Software industries. These industry veterans will enable R&D Logic to continue to deliver substantial value to the Life Sciences Industry," said Wanda Ionescu, Chief Executive Officer and President, R&D Logic Inc.
Press Release
R&D Logic CEO presents at the 2010 Corporate Performance Management Conference in New York.
Wanda Ionescu's presentation on "ROI on R&D" has spurned lively discussions among the participants at the conference. To download highlights of this presentation, please click here.
Meet R&D Logic at the 2010 Corporate Performance Management Conference in New York from January 31st through February 2nd, 2010.
R&D Logic CEO will moderate a roundtable discussion about "ROI on R&D" at this CPM Conference. The 2010 CPM Conference, Leveraging Analytics To Turn Data Into Insight, will focus on how companies can successfully harness data-management and business-intelligence techniques for fact-based decision-making. R&D Logic, a leader in providing inovative management solutions and services, will share its expertise and practical experience in supporting management of portolio-based companies.
R&D Logic's Unique Products and Services Offering Gaining Momentum with Leading Life Sciences Companies
"We chose R&D Logic's time collection and reporting tool because of R&D Logic's industry expertise, reputation for providing high quality software and services, and web based technology. R&D Time was implemented in less than three weeks and is now one of the key systems utilized to manage our internal resources and our collaborations with large pharmaceutical companies," says Andrew Smith, Assistant Controller of Portola Pharmaceuticals.
Press Release